Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response
Top Cited Papers
- 6 February 2007
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 21 (7) , 1345-1357
- https://doi.org/10.1096/fj.06-6769com
Abstract
Embryonic stem (ES) cells are promising for cardiac repair’ but directing their differentiation toward cardiomyocytes remains challenging. We investigated whether the heart guides ES cells toward cardiomyocytes in vivo and whether allogeneic ES cells were immunologically tolerated. Undifferentiated mouse ES cells consistently formed cardiac teratomas in nude or immunocompetent syngeneic mice. Cardiac teratomas contained no more cardiomyocytes than hind‐limb teratomas’ suggesting lack of guided differentiation. ES cells also formed teratomas in infarcted hearts’ indicating injury‐related signals did not direct cardiac differentiation. Allogeneic ES cells also caused cardiac teratomas’ but these were immunologically rejected after several weeks’ in association with increased inflammation and up‐regulation of class I and II histocompatibility antigens. Fusion between ES cells and cardiomyocytes occurred in vivo’ but was rare. Infarct autofluorescence was identified as an artifact that might be mistaken for enhanced GFP expression and true regeneration. Hence’ undifferentiated ES cells were not guided toward a cardiomyocyte fate in either normal or infarcted hearts’ and there was no evidence for allogeneic immune tolerance of ES cell derivatives. Successful cardiac repair strategies involving ES cells will need to control cardiac differentiation’ avoid introducing undifferentiated cells’ and will likely require immune modulation to avoid rejection.—Nussbaum, J., Minami, E., Laflamme, M. A., Virag, J. A. I., Ware, C. B., Masino, A., Muskheli, V., Pabon, L., Reinecke, H., Murry, C. E. Transplantation of undifferentiated mu‐rine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J. 21, 1345–1357 (2007)Keywords
Funding Information
- National Institutes of Health (R01 HL61553, P01 HL03174, R24 HL64387)
This publication has 47 references indexed in Scilit:
- Heart Disease and Stroke Statistics—2006 UpdateCirculation, 2006
- Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunctionJournal of the American College of Cardiology, 2003
- Infarct scar: a dynamic tissueCardiovascular Research, 2000
- Myogenic cell transplantation improves in vivo regional performance in infarcted rabbit myocardiumThe Journal of Heart and Lung Transplantation, 1999
- Survival, Integration, and Differentiation of Cardiomyocyte GraftsCirculation, 1999
- Regenerating functional myocardium: Improved performance after skeletal myoblast transplantationNature Medicine, 1998
- Skeletal myoblast transplantation for repair of myocardial necrosis.Journal of Clinical Investigation, 1996
- Arterial Delivery of Genetically Labelled Skeletal Myoblasts to the Murine Heart: Long-Term Survival and Phenotypic Modification of Implanted MyoblastsCell Transplantation, 1996
- Formation of Nascent Intercalated Disks Between Grafted Fetal Cardiomyocytes and Host MyocardiumScience, 1994
- The speed of healing of myocardial infarctionAmerican Heart Journal, 1939